Genomic and Immunophenotypic Landscape of Aggressive NK-Cell Leukemia-Reference-Cited by-同舟云学术

Genomic and Immunophenotypic Landscape of Aggressive NK-Cell Leukemia

Published:2020-06-24 Issue:9 Volume:44 Page:1235-1243
ISSN:0147-5185
Container-title:American Journal of Surgical Pathology
language:en
Short-container-title:

Author:

El Hussein Siba,Patel Keyur P.,Fang Hong,Thakral Beenu,Loghavi Sanam,Kanagal-Shamanna Rashmi,Konoplev Sergej,Jabbour Elias J.,Medeiros L. Jeffrey,Khoury Joseph D.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pathology and Forensic Medicine,Surgery,Anatomy

Reference20 articles.

1. EBV-negative aggressive NK-cell leukemia/lymphoma: a clinical and pathological study from a single institution;Gao;Mod Pathol,2017

2. EBV-negative aggressive NK-cell leukemia/lymphoma: clinical, pathologic, and genetic features;Nicolae;Am J Surg Pathol,2017

3. Integrated genomic analysis identifies deregulated JAK/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia;Huang;Cell Res,2018

4. Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target;Dufva;Nat Commun,2018

5. Validation of immunohistochemical assays for integral biomarkers in the NCI-MATCH EAY131 clinical trial;Khoury;Clin Cancer Res,2018

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From the midfacial destructive drama to the unfolding EBV story: a short history of EBV-positive NK-cell and T-cell lymphoproliferative diseases;Pathology;2024-10

2. Master regulator: p53’s pivotal role in steering NK-cell tumor patrol;Frontiers in Immunology;2024-08-09

3. Fifth Edition of the World Health Organization Classification of Tumors of the Hematopoietic and Lymphoid Tissues: Mature T-Cell, NK-Cell, and Stroma-Derived Neoplasms of Lymphoid Tissues;Modern Pathology;2024-08

4. Non-cutaneous extranodal mature T- and natural killer (NK)-cell neoplasms: clinicopathologic features, genetics and updates;Diagnostic Histopathology;2024-08

5. Expression of CD6 in Aggressive NK/T-cell Neoplasms and Assessment as a Potential Therapeutic Target: A Bone Marrow Pathology Group Study;Clinical Lymphoma Myeloma and Leukemia;2024-07